type_of_cancer: mixed
cancer_study_identifier: mixed_selpercatinib_2020
name: Mixed Tumors Selpercatinib RET Trial (MSK, Nat Commun. 2022)
short_name: Selpercatinib RET Trial (2020)
description: Targeted sequencing of Selpercatinib treated RET-driven solid cancers.
pmid: 35304457
citation: Ezra Y et al. Nat Commun 2022